Cargando…
Metabolic syndrome in relation to risk of meningioma
BACKGROUND: Meningioma is a frequent primary intracranial tumor, the etiology of which is potentially related to adiposity. Metabolic syndrome (MetS) is an increasingly common disease characterized by having at least three of the following conditions: central adiposity, arterial hypertension, dyslip...
Autores principales: | Seliger, Corinna, Meier, Christoph R, Becker, Claudia, Jick, Susan S, Proescholdt, Martin, Bogdahn, Ulrich, Hau, Peter, Leitzmann, Michael F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356799/ https://www.ncbi.nlm.nih.gov/pubmed/27903988 http://dx.doi.org/10.18632/oncotarget.13667 |
Ejemplares similares
-
Diabetes, use of metformin, and the risk of meningioma
por: Seliger, Corinna, et al.
Publicado: (2017) -
Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
por: Seliger, Corinna, et al.
Publicado: (2016) -
Antimicrobial drug use and the risk of glioma: A case–control study
por: Haedenkamp, Tareq M., et al.
Publicado: (2022) -
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
por: Anssar, Tareq M., et al.
Publicado: (2019) -
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016)